The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal insulin, Novo Nordisk announced. Some GLP-1 receptor agonists, particularly ...

The contribution of different nicotinic acetylcholine (ACh) receptor (nAChR) oligomers to nicotine addiction is being explored in mice, using novel strategies including deletion of nAChR subunit genes ...